Ads
related to: inc 500 fastest growing companiesbark.com has been visited by 100K+ users in the past month
Search results
OLB Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
Digital Journal· 23 hours agoThe Company disclaims any intention to, and undertakes no obligation to, update or revise any forward...0900 Ext. 333 SOURCE: The OLB Group, Inc. View the ...
Here's Why You Should Retain Henry Schein (HSIC) Stock for Now
Zacks via Yahoo Finance· 6 days agoIn the North American dental products market, the company faces stiff competition from Patterson...
Q1 2024 Rubicon Technologies Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoSo obviously, we feel good about our liquidity position going forward and our ability to fund the business as we move towards profitability. Yeah. I mean -- and then as we look at revenue going ...
MGO Global Announces First Quarter 2024 Results
Digital Journal· 23 hours agoDodi Handy, Director of Communications...accesswire.com ACCESSWIRE News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing ...
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Digital Journal· 2 days agoView the original press release on accesswire.com ACCESSWIRE News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing</ ...
CYIO Corporation Announces Commencement of Two-Year Financial Audit Spanning Calendar Years 2022 and...
Digital Journal· 23 hours agoThe newest, fastest-growing and most disruptive newswire available today. More from ACCESSWIRE Insurex.net ...Mosaic Data Science Named Top AI & Machine Learning ...
...Partnership with AI Data Engineering and Automation Pioneer, NOM NOM AI Inc. by Investee Company...
Digital Journal· 23 hours ago(TSXV:KSUM)(OTC:ALSCF)(FSE:1R60, WKN:A3ESVQ) ("Alset" or the "Company") is pleased to announce that on May 20, 2024, its investee company, Vertex AI Ventures ...
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New...
Digital Journal· 2 days agoThe Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a...Communications cosm@bdgcommunications.com +44 207 0971 ...
Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2...
Digital Journal· 7 days agoInvestor Relations Contact Corey ...ENTENTE Network of Companies virginiaamann@ententeinc.com +1 833 500 0061 SOURCE: Protagonist Therapeutics, Inc. View ...
Condor Receives Element79 Payment for Lucero Project
Digital Journal· 6 days agoAlthough the Company believes that the expectations reflected in applicable forward-looking statements are reasonable, there can...adequacy or accuracy of this news release ...